Anuh Pharma Limited (NSE:ANUHPHR)
76.02
+0.44 (0.58%)
May 25, 2026, 10:00 AM IST
Anuh Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 83.02 | 195.57 | 72.02 | 19.27 | 37.96 |
Short-Term Investments | 448.6 | 15.02 | 12.37 | 8.1 | - |
Trading Asset Securities | - | 523.56 | 538.17 | 503.4 | 214.69 |
Cash & Short-Term Investments | 531.61 | 734.15 | 622.56 | 530.77 | 252.65 |
Cash Growth | -27.59% | 17.93% | 17.29% | 110.08% | 91.21% |
Accounts Receivable | 2,386 | 2,159 | 1,899 | 1,712 | 1,357 |
Other Receivables | - | 97.33 | 61.96 | 39.14 | 5.25 |
Receivables | 2,395 | 2,261 | 1,968 | 1,756 | 1,370 |
Inventory | 1,478 | 744.81 | 754 | 726.36 | 799.23 |
Prepaid Expenses | - | 17.72 | 5.88 | 5.72 | 4.79 |
Restricted Cash | - | - | - | 30.5 | - |
Other Current Assets | 109.4 | 3.54 | 35.29 | 26.61 | 159.98 |
Total Current Assets | 4,513 | 3,762 | 3,385 | 3,076 | 2,587 |
Property, Plant & Equipment | 560.92 | 583.65 | 492.42 | 526.76 | 613.41 |
Long-Term Investments | 395.83 | 619.55 | 517.14 | 396.84 | 212.13 |
Other Intangible Assets | 5.29 | 1.21 | 1.58 | 1.31 | 1.83 |
Long-Term Deferred Tax Assets | 38.62 | 20.8 | 4.22 | 7.68 | - |
Other Long-Term Assets | 58.97 | 77.76 | 53.99 | 41.09 | 57.51 |
Total Assets | 5,574 | 5,066 | 4,457 | 4,050 | 3,472 |
Accounts Payable | 1,877 | 1,568 | 1,405 | 1,528 | 1,216 |
Accrued Expenses | 2.65 | 7.08 | 6.16 | 4.74 | 3.34 |
Short-Term Debt | - | 104.98 | 20.13 | - | 31.11 |
Current Portion of Leases | 0.58 | 3.3 | 2.91 | 0.67 | 2.06 |
Current Income Taxes Payable | 23.16 | 5.48 | - | - | - |
Other Current Liabilities | 127.07 | 95.85 | 92.72 | 80.29 | 56.81 |
Total Current Liabilities | 2,030 | 1,785 | 1,527 | 1,613 | 1,309 |
Long-Term Leases | - | 0.58 | 3.88 | 8.39 | 9.07 |
Pension & Post-Retirement Benefits | - | 12.92 | 11.05 | 9.91 | 9.72 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.48 |
Other Long-Term Liabilities | 21.42 | 7.39 | 2.75 | 5.93 | 5.69 |
Total Liabilities | 2,051 | 1,806 | 1,545 | 1,638 | 1,334 |
Common Stock | 501.12 | 250.56 | 250.56 | 250.56 | 250.56 |
Retained Earnings | - | 3,009 | 2,660 | 2,160 | 1,886 |
Comprehensive Income & Other | 3,021 | 1.14 | 1.31 | 1.69 | 1.3 |
Shareholders' Equity | 3,522 | 3,260 | 2,912 | 2,412 | 2,138 |
Total Liabilities & Equity | 5,574 | 5,066 | 4,457 | 4,050 | 3,472 |
Total Debt | 0.58 | 108.86 | 26.93 | 9.07 | 42.24 |
Net Cash (Debt) | 531.03 | 625.29 | 595.63 | 521.7 | 210.41 |
Net Cash Growth | -15.07% | 4.98% | 14.17% | 147.94% | - |
Net Cash Per Share | 5.30 | 6.24 | 5.94 | 5.21 | 2.10 |
Filing Date Shares Outstanding | 99.84 | 100.22 | 100.22 | 100.22 | 100.22 |
Total Common Shares Outstanding | 99.84 | 100.22 | 100.22 | 100.22 | 100.22 |
Working Capital | 2,483 | 1,977 | 1,858 | 1,463 | 1,278 |
Book Value Per Share | 35.28 | 32.53 | 29.06 | 24.07 | 21.33 |
Tangible Book Value | 3,517 | 3,259 | 2,911 | 2,411 | 2,136 |
Tangible Book Value Per Share | 35.23 | 32.52 | 29.04 | 24.06 | 21.31 |
Land | - | 15.59 | 15.59 | 113.07 | 113.07 |
Buildings | - | 146.73 | 146.73 | 146.73 | 146.73 |
Machinery | - | 941.3 | 767.32 | 723.6 | 713.5 |
Construction In Progress | - | 2.71 | 4.54 | - | 1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.